Large-scale testing (Phase 3)Study completedNCT01624233What this trial is testingA Study in Japanese Participants With Moderate-to-Severe PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 91
Large-scale testing (Phase 3)Study completedNCT03051217What this trial is testingTest the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic PsoriasisWho this might be right forModerate to Severe PsoriasisGeneralized Pustular Psoriasis and Erythrodermic Psoriasis UCB Biopharma S.P.R.L. 127
Post-approval studies (Phase 4)Study completedNCT00833729What this trial is testingThe Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to AdalimumabWho this might be right forPlaque Psoriasis Dermatrials Research 10
Large-scale testing (Phase 3)UnknownNCT02644954What this trial is testingAssessing the Efficacy and Safety of Metformin in Treatment of Moderate PsoriasisWho this might be right forPsoriasis Post Graduate Institute of Medical Education and Research, Chandigarh 40
Early research (Phase 1)UnknownNCT04367441What this trial is testingRandomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy SubjectsWho this might be right forModerate to Severe Plaque Psoriasis Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 62
Large-scale testing (Phase 3)Study completedNCT03875508What this trial is testingAssess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis AbbVie 108
Large-scale testing (Phase 3)Study completedNCT02267135What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp PsoriasisWho this might be right forChronic Scalp Psoriasis Novartis Pharmaceuticals 102
Large-scale testing (Phase 3)Not Yet RecruitingNCT07752108What this trial is testingZasocitinib in Adults With Non-pustular Palmoplantar PsoriasisWho this might be right forPalmoplantar Psoriasis Takeda 40
Large-scale testing (Phase 3)Ended earlyNCT01708629What this trial is testingEfficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis SubjectsWho this might be right forPlaque Psoriasis Bausch Health Americas, Inc. 1,881
Early research (Phase 1)Study completedNCT00937027What this trial is testingAminopterin Pharmacokinetic Study In Moderate to Severe PsoriasisWho this might be right forPsoriasis Syntrix Biosystems, Inc. 22
Testing effectiveness (Phase 2)WithdrawnNCT02011269What this trial is testingTSO for Plaque PsoriasisWho this might be right forPlaque Psoriasis Coronado Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT01300052What this trial is testingAN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type PsoriasisWho this might be right forPsoriasis Pfizer 68
Testing effectiveness (Phase 2)Study completedNCT01585233What this trial is testingA Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Astellas Pharma Global Development, Inc. 60
Not applicableStudy completedNCT04823247What this trial is testingObservational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE StudyWho this might be right forPlaque Psoriasis Almirall, S.A. 782
Not applicableLooking for participantsNCT06382051What this trial is testingModifying PEST for Psoriatic Arthritis ScreeningWho this might be right forPlaque PsoriasisPsoriatic Arthritis Novartis Pharmaceuticals 502
Testing effectiveness (Phase 2)Study completedNCT00147329What this trial is testingSafety and Efficacy Study of MM-093 in Patients With Chronic Plaque PsoriasisWho this might be right forPsoriasis Merrimack Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT02387801What this trial is testingThe Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe PsoriasisWho this might be right forPsoriasis Eli Lilly and Company 12
Testing effectiveness (Phase 2)Study completedNCT02106195What this trial is testingA Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis VulgarisWho this might be right forPsoriasis Vulgaris Kadmon Corporation, LLC 8
Large-scale testing (Phase 3)Active Not RecruitingNCT04862286What this trial is testingStudy to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977Who this might be right forPsoriasis AbbVie 132
Large-scale testing (Phase 3)Study completedNCT00251641What this trial is testingThe Effects of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis (Study P04271AM2)(COMPLETED)Who this might be right forPsoriasis Merck Sharp & Dohme LLC 868